Reduced renal toxicity of nanoparticular amphotericin B micelles prepared with partially benzylated poly-L-aspartic acid

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 8, 2006, Pages 1700-1705

  Yoo, Bong Kyu ^a   Jalil Miah, Md Abdul ^b   Lee, Eung Seok ^a   Han, Kun ^b  

^a Yeungnam University   (South Korea)

^b Chungbuk National University   (South Korea)

Author keywords

Molar absorptivity; Nanoparticular amphotericin B micelle; Nephrotoxicity; Partially benzylated poly L aspartic acid; Self aggregation

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; NANOPARTICLE; POLYASPARTIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BENZYLATION; BRUSH BORDER; COMPLEX FORMATION; CONTROLLED STUDY; DRUG ABSORPTION; DRUG COATING; DRUG FORMULATION; DRUG SYNTHESIS; KIDNEY TUBULE CELL; MALE; MICELLE; MOUSE; NEPHROTOXICITY; NONHUMAN; PREVALENCE; RAT; TRANSMISSION ELECTRON MICROSCOPY; ULTRASOUND;

AMPHOTERICIN B; ANIMALS; KIDNEY; MALE; MICELLES; MICROSCOPY, ELECTRON, TRANSMISSION; PARTICLE SIZE; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33746665968     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.1700     Document Type: Article

References (21)

1. Gallis H. A., Drew R. H., Pickard W. W., Rev. Infect. Dis., 12, 308-329 (1990).
2. Mullen A. B., Carter K. C., Baillie A. J., Antimicrob. Agents Chemother., 41, 2089-2092 (1997).
3. Saxena S., Ghosh P. C., Pharm. Res., 17, 1236-1242 (2000).
4. Townsend R. W., Zutshi A., Bekersky I., Drug Metab. Dispos., 29, 681-685 (2001).
5. Wingard J. R., Kubilis P., Lee L., Yee G., White M., Walshe L., Bowden R., Anaissie E., Hiemenz J., Lister J., Clin. Infect. Dis., 29, 1402-1407 (1999).
6. Todd J. H., Hottendorf G. H., Toxicol. Lett., 90, 217-221 (1997).
7. Whittem T., Parton K., Turner K., Antimicrob. Agents Chemother., 40, 1237-1241 (1996).
8. Swan S. K., Gilbert D. N., Kohlhepp S. J., Kohnen P. W., Bennett W. M., Antimicrob. Agents Chemother., 37, 347-348 (1993).
9. Sheppard R. C., Science Tools, 33, 122-129 (1986).
10. Yu B. G., Okano T., Kataoka K., Kwon G., J. Control. Release, 53, 131-136 (1998).
11. Yoo B., Miah M., Lee E., Han K., Arch. Pharm. Res., 28, 756-760 (2005).
12. Brajtburg J., Bolard J., Clin. Microbiol. Rev., 9, 512-531 (1996).
13. Kawaguchi H., Koiwai N., Ohtsuka Y., Miyamoto M., Sasakawa S., Biomaterials, 7, 61-66 (1986).
14. Liu X., Sun Q., Wang H., Zhang L., Wang J., Biomaterials, 26, 109-115 (2005).
15. Brajtburg J., Bolard J., Clin. Microbiol. Rev., 9, 512-531 (1996).
16. Barwicz J., Christian S., Gruda I., Antimicrob. Agents Chemother., 36, 2310-2315 (1992).
17. Yamashita K., Janout V., Bernard E., Armstrong D., Regen S., J. Am. Chem. Soc., 117, 6249-6253 (1995).
18. Kaloyanides G., Nephrol. Dial. Transplant., 9 (Suppl. 4), 130-134 (1994).
19. Kacew S., J. Pharmacol. Exp. Ther., 248, 360-366 (1989).
20. Kojima R., Ito M., Suzuki Y., Jpn. J. Pharmacol., 53, 347-358 (1990).
21. Szoka F. C., Jr., Milholland D., Barza M., Antimicrob. Agents Chemother., 31, 421-429 (1987).